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Background: TAVI is currently transforming the treatment of non-operable and high-risk patients (pts) with severe aortic stenosis. However, surgical 
risk is known to be increased for pts with reduced left-ventricular ejection fraction (EF) and only few data exist about its impact in the setting of TAVI.
We therefore sought to analyze the outcome of our single-center transfemoral TAVI patient cohort focussing on baseline EF.
methods: Since 2006 358 pts underwent TF-TAVI (ES n=247; MCV n=111). We analyzed procedural data and outcome. For analysis, pts were 
divided into 4 groups (1 EF>55%; 2 45-54%; 3 30-44%; 4 <30%) according to their baseline EF using the “ESC Recommendations for Chamber 
quantification”.
results: TAVI was successful in 99%. Except for EuroScore there were no significant differences between groups(1 n=135; 2 n=108; 3 n=74; 4 
n=41). We found a significantly higher 30-day mortality in group 4 (5 vs. 8 vs. 11 vs. 26%; p<0.001) and cumulative 1-year survival suggested the 
worst outcome in patients with severely reduced EF (91 vs. 90 vs. 84 vs. 64%; p<0.001). Interestingly, complication rates were not different between 
groups (21 vs. 16 vs. 19 vs. 23; p=0.946).
conclusion: Severely reduced EF is associated with higher mortality after TAVI at 30 days and 1 year compared to normal or moderately reduced 
EF. However, 11% of our pts had an EF<30% and 74% were successfully treated. Therefore, strategies (eg routine stress echo) need to be evaluated 
in order to determine which of these high-risk pts may benefit from TAVI.
